PsyBio Therapeutics Corp.

PSYBF · OTC
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Operating Activities
Net Income-$145-$811-$942-$922
Dep. & Amort.$0$38$38$38
Deferred Tax$0$0$0-$4
Stock-Based Comp.$0$220$2$84
Change in WC-$211$195$731$90
Other Non-Cash$695$3$4$5
Operating Cash Flow$340-$355-$166-$708
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$5-$3
Inv. Sales/Matur.$0$0$54$857
Other Inv. Act.$1$0$0$3
Investing Cash Flow$1$0$49$857
Financing Activities
Debt Repay.$0$0-$14-$27
Stock Issued$244$294$156$0
Stock Repurch.$0$0$0-$7
Dividends Paid$0$0$0$0
Other Fin. Act.$314-$3-$8$7
Financing Cash Flow$559$291$143-$27
Forex Effect$1-$1-$0$1
Net Chg. in Cash-$49-$65-$23$122
Supplemental Information
Beg. Cash$92$157$181$59
End Cash$43$92$157$181
Free Cash Flow$340-$355-$166-$708